Current treatment of craniosynostosis and future therapeutic directions

Frontiers of Oral Biology

Volumn 12, Issue , 2008, Pages 209-230

  Wan, Derrick C ^a,b   Kwan, Matthew D ^a,c   Lorenz, H Peter ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRANIOFACIAL SYNOSTOSIS; FORECASTING; GENE THERAPY; GENETICS; HUMAN; METHODOLOGY; MUTATION; PLASTIC SURGERY; REVIEW; SIGNAL TRANSDUCTION;

CRANIOSYNOSTOSES; FORECASTING; GENE THERAPY; HUMANS; MUTATION; RECONSTRUCTIVE SURGICAL PROCEDURES; SIGNAL TRANSDUCTION;

EID: 45849111486     PISSN: 14202433     EISSN: 16623770     Source Type: Book Series    
DOI: 10.1159/000115043     Document Type: Article

References (86)

1. Otto AW: Lehrbuch der Pathologischen Anatomie. Berlin, Rucher, 1830.
2. Virchow R: Über den Cretinismus, namentlich in Franken, und über pathologische Schädelformen. Verh Phys Med Gesellsch Würzburg 1851;2:231-271.
3. Park EA, Powers GF: Acrocephaly and scaphocephaly with symmetrically distributed malformations of the extremities. Am J Dis Child 1920;20:235-315.
4. Moss ML: The pathogenesis of premature cranial synostosis in man. Acta Anat 1959;37:351-370.
5. Tessier P: Total facial osteotomy. Crouzon's syndrome, Apert's syndrome: oxycephaly, scaphocephaly, turricephaly (in French). Ann Chir Plast 1967;12:273-286.
6. Posnick JC: Craniofacial syndromes and anomalies; in Posnick JC (ed): Craniofacial and Maxillofacial Surgery in Children and Young Adults. Philadelphia, Saunders, 2000, vol 1, pp 391-527.
7. Moss ML: Experimental alteration of sutural area morphology. Anat Rec 1957;127:569-589.
8. Grabb WC, Smith JW, Aston SJ: Plastic Surgery, ed 4. Boston, Little, Brown, 1991
9. Renier D, Sainte-Rose C, Marchac D, Hirsch JF: Intracranial pressure in craniostenosis. J Neurosurg 1982;57:370-377.
10. Gault DT, Renier D, Marchac D, Jones BM: Intracranial pressure and intracranial volume in children with craniosynostosis. Plast Reconstr Surg 1992;90:377-381.
11. Kreiborg S, Cohen MM Jr: The infant Apert skull. Neurosurg Clin North Am 1991;2:551-554.
12. Newman SA: Ophthalmic features of craniosynostosis. Neurosurg Clin North Am 1991;2:587-610.
13. Marchac D, Renier D: The 'floating forehead'. Early treatment of craniofacial stenosis (in French). Ann Chir Plast 1979;24:121-126. (Pubitemid 9225146)
14. Panchal J, Uttchin V: Management of craniosynostosis. Plast Reconstr Surg 2003;111:2032-2049.
15. Benson ML, Oliverio PJ, Yue NC, Zinreich SJ: Primary craniosynostosis: imaging features. AJR Am J Roentgenol 1996;166:697-703. (Pubitemid 26065186)
16. Aviv RI, Rodger E, Hall CM: Craniosynostosis. Clin Radiol 2002;57:93-102.
17. Panchal J, Marsh JL, Park TS, Kaufman B, Pilgram T: Photographic assessment of head shape following sagittal synostosis surgery. Plast Reconstr Surg 1999;103:1585-1591. (Pubitemid 29206860)
18. Blaumeiser B, Loquet P, Wuyts W, Nothen MM: Prenatal diagnosis of Pfeiffer syndrome type II. Prenat Diagn 2004;24:644-646. (Pubitemid 39108573)
19. Robson CD, Barnewolt CE: MR imaging of fetal head and neck anomalies. Neuroimaging Clin North Am 2004;14:273-291, viii. (Pubitemid 38739162)
20. Kaufman BA, Muszynski CA, Matthews A, Etter N: The circle of sagittal synostosis surgery. Semin Pediatr Neurol 2004;11:243-248. (Pubitemid 40380683)
21. Persing JA, Edgerton MT, Jane JA: Scientific Foundations and Surgical Treatment of Craniosynostosis. Baltimore, Williams & Wilkins, 1989.
22. Jimenez DF, Barone CM: Endoscopic craniectomy for early surgical correction of sagittal craniosynostosis. J Neurosurg 1998;88:77-81. (Pubitemid 28018967)
23. Barone CM, Jimenez DF: Endoscopic craniectomy for early correction of craniosynostosis. Plast Reconstr Surg 1999;104:1965-1973.
24. Panchal J, Marsh JL, Park TS, Kaufman B, Pilgram T, Huang SH: Sagittal craniosynostosis outcome assessment for two methods and timings of intervention. Plast Reconstr Surg 1999;103:1574-1584. (Pubitemid 29206859)
25. Albin RE, Hendee RW Jr, O'Donnell RS, Majure JA: Trigonocephaly: refinements in reconstruction. Experience with 33 patients. Plast Reconstr Surg 1985;76:202-211.
26. Hansen M, Mulliken JB: Frontal plagiocephaly. Diagnosis and treatment. Clin Plast Surg 1994;21:543-553.
27. Persing JA, Jane JA: Treatment of syndromic and nonsyndromic bilateral coronal synostosis in infancy and childhood. Neurosurg Clin North Am 1991;2:655-663.
28. Ellenbogen RG, Gruss JS, Cunningham ML: Update on craniofacial surgery: the differential diagnosis of lambdoid synostosis/posterior plagiocephaly. Clin Neurosurg 2000;47:303-318.
29. Whitaker LA, Munro IR, Salyer KE, Jackson IT, Ortiz-Monasterio F, Marchac D: Combined report of problems and complications in 793 craniofacial operations. Plast Reconstr Surg 1979;64:198-203. (Pubitemid 9215474)
30. Davies DW, Munro IR: The anesthetic management and intraoperative care of patients undergoing major facial osteotomies. Plast Reconstr Surg 1975;55:50-55.
31. McCarthy JG, Epstein F, Sadove M, Grayson B, Zide B: Early surgery for craniofacial synostosis: an 8-year experience. Plast Reconstr Surg 1984;73:521-533.
32. Fearon JA, Yu J, Bartlett SP, Munro IR, Chir B, Whitaker L: Infections in craniofacial surgery: a combined report of 567 procedures from two centers. Plast Reconstr Surg 1997;100:862-868. (Pubitemid 27386226)
33. Wilkie AOM, Slaney SF, Oldridge M, Poole MD, Ashworth JG, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, et al: Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 1995;9:165-171.
34. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S, et al: A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 1994;8:269-274. (Pubitemid 24338739)
35. Wilkie AOM, Morriss-Kay GM, Jones EY, Heath JK: Functions of fibroblast growth factors and their receptors. Curr Biol 1995;5:500-507.
36. Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M: Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci USA 2001;98:7182-7187. (Pubitemid 32567923)
37. Bellus GA, Gaudenz K, Zackai EH, Clarke LA, Szabo J, Francomano CA, Muenke M: Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet 1996;14:174-176. (Pubitemid 26338798)
38. Tavormina PL, Shiang R, Thompson LM, Zhu YZ, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ: Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995;9:321-328.
39. Warren SM, Longaker MT: New directions in plastic surgery research. Clin Plast Surg 2001;28:719-730. (Pubitemid 33032405)
40. Nakamura T, Hanada K, Tamura M, Shibanushi T, Nigi H, Tagawa M, Fukumoto S, Matsumoto T: Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 1995;136:1276-1284.
41. Moore R, Ferretti P, Copp A, Thorogood P: Blocking endogenous FGF-2 activity prevents cranial osteogenesis. Dev Biol 2002;243:99-114. (Pubitemid 34208406)
42. Mehrara BJ, Mackool RJ, McCarthy JG, Gittes GK, Longaker MT: Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast Reconstr Surg 1998;102:1805-1820. (Pubitemid 28518502)
43. Most D, Levine JP, Chang J, Sung J, McCarthy JG, Schendel SA, Longaker MT: Studies in cranial suture biology: up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast Reconstr Surg 1998;101:1431-1440. (Pubitemid 28234645)
44. Gosain AK, Recinos RF, Agresti M, Khanna AK: TGF-beta1, FGF-2, and receptor mRNA expression in suture mesenchyme and dura versus underlying brain in fusing and nonfusing mouse cranial sutures. Plast Reconstr Surg 2004;113:1675-1684. (Pubitemid 39201798)
45. Warren SM, Brunet LJ, Harland RM, Economides AN, Longaker MT: The BMP antagonist noggin regulates cranial suture fusion. Nature 2003;422:625-629. (Pubitemid 36460417)
46. Greenwald JA, Mehrara BJ, Spector JA, Warren SM, Fagenholz PJ, Smith LE, Bouletreau PJ, Crisera FE, Ueno H, Longaker MT: In vivo modulation of FGF biological activity alters cranial suture fate. Am J Pathol 2001;158:441-452. (Pubitemid 32158607)
47. Zhou YX, Xu X, Chen L, Li C, Brodie SG, Deng CX: A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet 2000;9:2001-2008. (Pubitemid 30642665)
48. Chen L, Li D, Li C, Engel A, Deng CX: A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 2003;33:169-178. (Pubitemid 37117129)
49. Ignelzi MA Jr, Wang W, Young AT: Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures. J Bone Miner Res 2003;18:751-759. (Pubitemid 36899325)
50. Liu YH, Tang Z, Kundu RK, Wu L, Luo W, Zhu D, Sangiorgi F, Snead ML, Maxson RE: Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. Dev Biol 1999;205:260-274. (Pubitemid 29066384)
51. Liu YH, Kundu R, Wu L, Luo W, Ignelzi MA Jr, Snead ML, Maxson RE Jr: Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc Natl Acad Sci USA 1995;92:6137-6141.
52. el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D, Bourgeois P, Bolcato-Bellemin AL, Munnich A, Bonaventure J: Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 1997;15:42-46. (Pubitemid 27014948)
53. Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz de Luna RI, Garcia Delgado C, Gonzalez-Ramos M, Kline AD, Jabs EW: Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 1997;15:36-41. (Pubitemid 27014947)
54. Carver EA, Oram KF, Gridley T: Craniosynostosis in Twist heterozygous mice: a model for Saethre-Chotzen syndrome. Anat Rec 2002;268:90-92.
55. Lee MS, Lowe GN, Strong DD, Wergedal JE, Glackin CA: TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 1999;75:566-577. (Pubitemid 29529912)
56. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, et al: A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005;37:275-281. (Pubitemid 41716254)
57. Roth DA, Gold LI, Han VK, McCarthy JG, Sung JJ, Wisoff JH, Longaker MT: Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast Reconstr Surg 1997;99:300-309. (Pubitemid 127747870)
58. Opperman LA, Nolen AA, Ogle RC: TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Miner Res 1997;12:301-310.
59. Opperman LA, Chhabra A, Cho RW, Ogle RC: Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro. J Craniofac Genet Dev Biol 1999;19:164-173. (Pubitemid 29525107)
60. Opperman LA, Galanis V, Williams AR, Adab K: Transforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliteration. Orthod Craniofac Res 2002;5:5-16.
61. Brunet LJ, McMahon JA, McMahon AP, Harland RM: Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 1998;280:1455-1457. (Pubitemid 28264842)
62. Nacamuli RP, Fong KD, Lenton KA, Song HM, Fang TD, Salim A, Longaker MT: Expression and possible mechanisms of regulation of BMP3 in rat cranial sutures. Plast Reconstr Surg 2005;116:1353-1362. (Pubitemid 41456507)
63. Takao M, Hino J, Takeshita N, Konno Y, Nishizawa T, Matsuo H, Kangawa K: Identification of rat bone morphogenetic protein-3b (BMP-3b), a new member of BMP-3. Biochem Biophys Res Commun 1996;219:656-662. (Pubitemid 26090318)
64. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Baban K, Affolter M, Vale WW, Belmonte JC, et al: Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cystine knot protein. J Bone Joint Surg Am 2003;85-A(suppl 3):52-58. (Pubitemid 36951117)
65. Daluiski A, Engstrand T, Bahamonde ME, Gamer LW, Agius E, Stevenson SL, Cox K, Rosen V, Lyons KM: Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet 2001;27:84-88. (Pubitemid 32044524)
66. Nacamuli RP, Song HM, Fang TD, Fong KD, Mathy JA, Shi YY, Salim A, Longaker MT: Quantitative transcriptional analysis of fusing and nonfusing cranial suture complexes in mice. Plast Reconstr Surg 2004;114:1818-1825. (Pubitemid 40361893)
67. Ting K, Vastardis H, Mulliken JB, Soo C, Tieu A, Do H, Kwong E, Bertolami CN, Kawamoto H, Kuroda S, et al: Human NELL-1 expressed in unilateral coronal synostosis. J Bone Miner Res 1999;14:80-89. (Pubitemid 29021607)
68. Zhang X, Carpenter D, Bokui N, Soo C, Miao S, Truong T, Wu B, Chen I, Vastardis H, Tanizawa K, et al: Overexpression of Nell-1, a craniosynostosis- associated gene, induces apoptosis in osteoblasts during craniofacial development. J Bone Miner Res 2003;18:2126-2134. (Pubitemid 37463306)
69. Twigg SR, Kan R, Babbs C, Bochukova EG, Robertson SP, Wall SA, Morriss-Kay GM, Wilkie AO: Mutations of ephrin-B1(EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc Natl Acad Sci USA 2004;101:8652-8657. (Pubitemid 38745826)
70. Tang XX, Biegel JA, Nycum LM, Yoshioka A, Brodeur GM, Pleasure DE, Ikegaki N: cDNA cloning, molecular characterization, and chromosomal localization of NET (EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain. Genomics 1995;29:426-437.
71. Antikainen T: Silicon membrane interpositioning for the prevention of skull deformity following experimental craniosynostosis. Childs Nerv Syst 1993;9:321-324. (Pubitemid 23344215)
72. Stelnicki EJ, Vanderwall K, Harrison MR, Longaker MT, Kaban LB, Hoffman WY: The in utero correction of unilateral coronal craniosynostosis. Plast Reconstr Surg 1998;101:287-296. (Pubitemid 28106329)
73. Powers CJ, McLeskey SW, Wellstein A: Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000;73:165-197.
74. Ueno H, Gunn M, Dell K, Tseng A, Williams L: A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptors. J Biol Chem 1992;267:1470-1476.
75. Dorn G, Patel S, Wotherspoon G, Hemmings-Mieszczak M, Barclay J, Natt FJ, Martin P, Bevan S, Fox A, Ganju P, et al: siRNA relieves chronic neuropathic pain. Nucleic Acids Res 2004;32:e49.
76. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J: RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003;9:347-351. (Pubitemid 36362792)
77. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, et al: Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004;432:173-178. (Pubitemid 39545841)
78. Enlow DH: Facial Growth, ed. Philadelphia, Saunders, 1990.
79. Lomri A, Lemonnier J, Delannoy P, Marie PJ: Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray. J Bone Miner Res 2001;16:705-712. (Pubitemid 32230599)
80. Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, Liao EY: Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 2005;309:99-109. (Pubitemid 41191227)
81. Spector JA, Mathy JA, Warren SM, Nacamuli RP, Song HM, Lenton K, Fong KD, Fang DT, Longaker MT: FGF-2 acts through an ERK1/2 intracellular pathway to affect osteoblast differentiation. Plast Reconstr Surg 2005;115:838-852. (Pubitemid 40316428)
82. Kim HJ, Lee MH, Park HS, Park MH, Lee SW, Kim SY, Choi JY, Shin HI, Ryoo HM: Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure. Dev Dyn 2003;227:335-346.
83. Moursi AM, Winnard PL, Fryer D, Mooney MP: Delivery of transforming growth factor-beta2-perturbing antibody in a collagen vehicle inhibits cranial suture fusion in calvarial organ culture. Cleft Palate Craniofac J 2003;40:225-232. (Pubitemid 36613180)
84. Chong SL, Mitchell R, Moursi AM, Winnard P, Losken HW, Bradley J, Ozerdem OR, Azari K, Acarturk O, Opperman LA, et al: Rescue of coronal suture fusion using transforming growth factorbeta 3 (Tgf-beta 3) in rabbits with delayed-onset craniosynostosis. Anat Rec A Discov Mol Cell Evol Biol 2003;274:962-971. (Pubitemid 37267780)
85. Opperman LA, Moursi AM, Sayne JR, Wintergerst AM: Transforming growth factor-beta 3 (Tgfbeta3) in a collagen gel delays fusion of the rat posterior interfrontal suture in vivo. Anat Rec 2002;267:120-130. (Pubitemid 34587366)
86. Wu XB, Li Y, Schneider A, Yu W, Rajendren G, Iqbal J, Yamamoto M, Alam M, Brunet LJ, Blair HC, et al: Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest 2003;112:924-934. (Pubitemid 38063750)